Evidence map›Paper›PMID 28649450›Full record

ArticleJournal of clinical and translational science2017

The Northwest Participant and Clinical Interactions Network: Increasing opportunities for patients to participate in research across the Northwestern United States.

Laura-Mae Baldwin, Laurie Hassell, Cindi Laukes, Michelle Doyle, Anne Reedy, Brenda Mollis, Sandra Albritton, Elizabeth Ciemins, Robert Coker, Jeannine Brant and 3 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Laura-Mae BaldwinInstitute of Translational Health Sciences, Seattle, WA, USA.
Laurie HassellInstitute of Translational Health Sciences, Seattle, WA, USA.
Cindi LaukesNeural Injury Center, University of Montana, Missoula, MT, USA.
Michelle DoyleInstitute of Translational Health Sciences, Seattle, WA, USA.
Anne ReedyMultiCare Health System, Tacoma, WA, USA.
Brenda MollisInstitute of Translational Health Sciences, Seattle, WA, USA.
Sandra AlbrittonKootenai Health, Coeur d'Alene, ID, USA.
Elizabeth CieminsBillings Clinic, Billings, MT, USA.
Robert CokerInstitute of Arctic Biology, University of Alaska, Fairbanks, AK, USA.
Jeannine BrantBillings Clinic, Billings, MT, USA.
Katherine R TuttleInstitute of Translational Health Sciences, Seattle, WA, USA.
Laura BakerInstitute of Translational Health Sciences, Seattle, WA, USA.
Bonnie RamseyInstitute of Translational Health Sciences, Seattle, WA, USA.

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Institute of Translational Health SciencesUL1TR000423 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$49.4M
NCATS NIH HHS UL1 TR000423NCATS NIH HHS UL1 TR002319
6 · The paper itself

Abstract

introductionThe Institute of Translational Health Sciences (ITHS) promotes and supports translational research collaboration between clinicians, communities, and investigators across the five-state Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) region. The ITHS has developed a collaborative regional clinical research network, the Northwest Participant & Clinical Interactions Network (NW PCI), involving 12 diverse clinical health systems and academic institutions.

methodsThis descriptive article details NW PCI's development, infrastructure and governance, tools, characteristics, and initial outcomes.

resultsRegional NW PCI sites are conducting largely industry-sponsored studies; they are interested in including more grant-funded research. Regional NW PCI sites had over 1,240 open studies involving over 6700 patients in 2016. NW PCI trials are largely industry-sponsored; NW PCI sites are interested in including more grant-funded research. In its first three years, the NW PCI Coordinating Center facilitated regional sites' participation in 34 new grant and contract applications across diverse topics.

conclusionThe NW PCI model supports the goals of the developing CTSA Trial Innovation Network by increasing access to cutting-edge research across the Northwestern U.S., by supporting investigators seeking diverse populations, including those with rare diseases, for their research studies, and by providing settings to test implementation and dissemination of effective interventions.

Indexed as

clinical research networkclinician-engaged researchcommunity-based researchTranslational research

Identifiers

PMID28649450
PMCPMC5471901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.